| Speakers|
| Who Will Engage me in “Candid Conversations” Panels? | Who will Re-Inspire me and Motivate me to Push Harder? - P. Roy Vagelos, former Chief Executive Officer, Merck & Co
- Leonard Sacks, Deputy Director, Critical Path Program, US Food and Drug Administration (FDA)
- Victoria Hale, Founder, The Institute for OneWorld Health
- Steven Altschuler, President & Chief Executive Officer, Children’s Hospital of Philadelphia (CHOP)
| Can the Current R&D Business Model Survive?
- William D. Matthews, Vice President, BIO Research & Development Management Operations, Centocor R&D
- Joel C. Scherer, Managing Director, Chorus R&D Initiative, Eli Lilly & Co
- Anders Ekblom, Vice President and Head Clinical Development, Global Drug Development, AstraZeneca
| Clinical Trials Transformation Initiative Executive Committee Update
- Glenn Gormley, former Global Head of Clinical Development and Medical Affairs at Novartis, former Chief Medical Officer at AstraZeneca, Chief Executive Officer, Gemin X
- Dr. Jay Siegel, Group President, Research & Development, Biotechnology, Immunology, and Oncology, Johnson & Johnson
- Judith M. Kramer, Associate Professor of Medicine, Duke University Medical Center, Executive Director, Clinical Trials Transformation Initiative (CTTI)
| Who will Share Case Studies of the Clinical Trials Experiences?
- Amanda Varns, Associate Director, Clinical Data Management, Amylin Pharmaceuticals
- Anthony Carita, Director, Clinical Outsourcing, Otsuka Pharmaceuticals
- Brad Allen, Clinical Trial Enrollment Optimization Consultant, Global Enrollment Optimization, Eli Lilly & Co
- Craig Lipset, Director, Global Clinical Technology, Pfizer
- Daniel M. Ulrey, President and Chief Executive Officer, MCSI
- Grace Woo, Director, Monitoring Systems & Data Flow and Chairman, CRF/Plan Review Committee, International Clinical Development, Sanofi-Aventis
- Gretchen Goller, Patient Recruitment and Compliance Specialist, sanofi-aventis
- Jeffrey J. DiFrancesco, Assistant Professor, Mayes College of Healthcare Business and Policy, University of the Sciences in Philadelphia
- Jennifer Green, Regional Clinical Research Associate, sanofi-aventis, U.S., Inc.
- Jim George, Deputy Director, Clinical Development, Sanofi-Pasteur
- Keith Wilner, Senior Director, Oncology Clinical Development, Pfizer
- Kristin Eilenberg, Global Customer Solutions, Explorer and Evangelist, Innovation and New Media, Eli Lilly & Co
- Maria G. Rachelle, Director, Clinical Trial Management, Genentech, Inc.
- Peter DiBiaso, Senior Clinical Operations Director, Clinical Research & Development, Shire Pharmaceuticals
- Peter J. Conroy, Associate Director, Contracts & Finance, U.S. Clinical Operations, Alcon Research, Ltd.
- Ramzi Benamar, Finance Director & Karen Gallagher, Clinical Program Director, Shire
- Richard Robinson, Senior Clinical Project Leader, Cardio-Thrombosis, US-CRU, sanofi-aventis, U.S. Inc.
- Rob Hockney, Director, Alliance Management, Strategy Planning & Business Development, AstraZeneca
- Robert Musterer, Direct & Head, CoE Clinical Systems Support, R&D Info, Bayer Healthcare
- Thomas P. Lawler III, Senior Director, Clinical Project Management, AstraZeneca Pharmaceuticals
- Victoria A. Dwyer, Director, Development Operations, Head of CORE Research Sites, Pfizer Global Research & Development
| How Payer Perspectives Might Shape the Future of Drug Development Strategies
- Elizabeth Bewley, Vice President, Strategic Planning, Johnson & Johnson Health Care Systems, Inc.
- Gergana Zlateva, Director, Global Outcomes Research, Pfizer
- Suzanne McDonald, Vice President, government and External Affairs, Takeda Pharmaceuticals North America
- Helen Sherman, Chief Pharmacy Officer, Pharmacy Services, The Regence Group
| The Keys to Clinical Operations Success
- Amirtha Naadimuthu, Vice President and Head of US Clinical Research, sanofi-aventis
- Craig Landau, Vice President, Chief Medical Officer, Head of Clinical Research, Purdue Pharma
- James Kirwin, Associate Vice President, Global Clinical Operations, Wyeth Pharmaceuticals
- Mark Bach, Vice President, Clinical Research Operations Worldwide, Merck & Co
- Moderator: Speaker TBD, CampbellAlliance
| How Can you Fully Enroll a Trial in One Day? Overcoming Patient Recruitment Bottlenecks
- Joseph Kim, Patient Recruitment Specialist, Merck & Co
- Gretchen Goller, Patient Recruitment/Compliance Specialist, Operations, sanofi-aventis
- Brad Allen, Clinical Trial Enrollment Optimization Consultant, Global Enrollment Optimization, Eli Lilly & Co
| How Can you Leverage Offshore Capabilities, Align your Strategy, and Maintain a Successful Global Partnership
- Julia Santos, Worldwide Associate Director, Strategic Outsourcing, Johnson & Johnson
- Robert Ward, Vice President, Alliance Management, NPS Pharmaceuticals
- Kendra Eager, Assistant Vice President, Global Business Development, Wyeth Pharmaceuticals
| What Can We Learn from the Small Pharma/Biotech Model of Clinical Development?
- Maria G. Rachelle, Director, Clinical Trial Management, Genentech, Inc.
- Rashieda Gluck, Head of Clinical Operations, Vifor Pharma
- Deborah Profit, Associate Director, Clinical Operations, Global Clinical Development, Otsuka Pharmaceutical Development
| Who Will Help me Find Solutions for Increased Trial Success?
- Roger Smith, Chief Information Officer & Vice President of Operations, Acurian, Inc.
- Viq Pervaaz, Vice President, Global Project Management, MDS Pharma Services
- Christopher Sleat, Chief Operating Officer, Chief Technology Officer, Inclinix, Inc.
- Tim Dietlin, Vice President, Clinical Development Practice, Campbell Alliance
- David Friend, Director of Key Account Mangement, MedNet Solutions, Inc.
- Joyce Frey-Vasconcells, Executive Director, PharmaNet Consulting
- William M. Egan, Vice President, PharmaNet Consulting
- Andrew C. Chang, Executive Director, PharmaNet Consulting
Joyce Frey- William M.
| Are M&A’s the New R&D? How Pharma/Biotech R&D Collaboration Is Driving Pipeline Innovation
- Christoph Schnorr, Senior Vice President, Global Clinical Operations, Merck Serono International
- David Rosen, Vice President and Head of Development and Commercial Strategic Alliances, Pfizer Global R&D
- Francis Cuss, Senior Vice President, Discovery and Drug Development, Bristol-Myers Squibb
| Strategic Development Towards FDA Approval
- Joyce Frey-Vasconcells, Fomer Deputy Director, FDA, Pharmanet
| Where Will we Find the Next Therapeutic Area Breakthrough and How Will it Impact your Clinical Trials - Perry Nisen, Senior Vice President, Cancer Research, GlaxoSmithKline (Oncology)
- Scott Patterson, Senior Director of Statistical Science, Vaccines and Infectious Disease, Wyeth (Infectious Disease)
- Marc Cantillon, Senior Director, CNS Clinical Research, Schering-Plough Research Institute (Oncology)
| Where Will we Find the Next Big Global Site? Gaining Confidence in Expanding your Operations beyond China and India
- Chandrashekhar Potkar, Director, Clinical Research, Pfizer India
- Grace Woo, Director, International Clinical Operations, sanofi-aventis
- Murray Stewart, Vice President, Clinical Europe, GlaxoSmithKline
|
|